178 related articles for article (PubMed ID: 32816994)
1. PGAP6, a GPI-specific phospholipase A2, has narrow substrate specificity against GPI-anchored proteins.
Lee GH; Fujita M; Nakanishi H; Miyata H; Ikawa M; Maeda Y; Murakami Y; Kinoshita T
J Biol Chem; 2020 Oct; 295(42):14501-14509. PubMed ID: 32816994
[TBL] [Abstract][Full Text] [Related]
2. A GPI processing phospholipase A2, PGAP6, modulates Nodal signaling in embryos by shedding CRIPTO.
Lee GH; Fujita M; Takaoka K; Murakami Y; Fujihara Y; Kanzawa N; Murakami KI; Kajikawa E; Takada Y; Saito K; Ikawa M; Hamada H; Maeda Y; Kinoshita T
J Cell Biol; 2016 Dec; 215(5):705-718. PubMed ID: 27881714
[TBL] [Abstract][Full Text] [Related]
3. Characterization of the glycosylphosphatidylinositol-anchor signal sequence of human Cryptic with a hydrophilic extension.
Watanabe K; Nagaoka T; Strizzi L; Mancino M; Gonzales M; Bianco C; Salomon DS
Biochim Biophys Acta; 2008 Dec; 1778(12):2671-81. PubMed ID: 18930707
[TBL] [Abstract][Full Text] [Related]
4. Hematopoietic stem cells are regulated by Cripto, as an intermediary of HIF-1α in the hypoxic bone marrow niche.
Miharada K; Karlsson G; Rehn M; Rörby E; Siva K; Cammenga J; Karlsson S
Ann N Y Acad Sci; 2012 Aug; 1266():55-62. PubMed ID: 22901256
[TBL] [Abstract][Full Text] [Related]
5. Biochemical and Cellular Analysis Reveals Ligand Binding Specificities, a Molecular Basis for Ligand Recognition, and Membrane Association-dependent Activities of Cripto-1 and Cryptic.
Aykul S; Parenti A; Chu KY; Reske J; Floer M; Ralston A; Martinez-Hackert E
J Biol Chem; 2017 Mar; 292(10):4138-4151. PubMed ID: 28126904
[TBL] [Abstract][Full Text] [Related]
6. Membrane-anchorage of Cripto protein by glycosylphosphatidylinositol and its distribution during early mouse development.
Minchiotti G; Parisi S; Liguori G; Signore M; Lania G; Adamson ED; Lago CT; Persico MG
Mech Dev; 2000 Feb; 90(2):133-42. PubMed ID: 10640699
[TBL] [Abstract][Full Text] [Related]
7. The CRIPTO/FRL-1/CRYPTIC (CFC) domain of human Cripto. Functional and structural insights through disulfide structure analysis.
Foley SF; van Vlijmen HW; Boynton RE; Adkins HB; Cheung AE; Singh J; Sanicola M; Young CN; Wen D
Eur J Biochem; 2003 Sep; 270(17):3610-8. PubMed ID: 12919325
[TBL] [Abstract][Full Text] [Related]
8. Requirement of glycosylphosphatidylinositol anchor of Cripto-1 for trans activity as a Nodal co-receptor.
Watanabe K; Hamada S; Bianco C; Mancino M; Nagaoka T; Gonzales M; Bailly V; Strizzi L; Salomon DS
J Biol Chem; 2007 Dec; 282(49):35772-86. PubMed ID: 17925387
[TBL] [Abstract][Full Text] [Related]
9. Exogenous Cripto-1 Suppresses Self-Renewal of Cancer Stem Cell Model.
Alam MJ; Takahashi R; Afify SM; Oo AKK; Kumon K; Nawara HM; Khayrani AC; Du J; Zahra MH; Seno A; Salomon DS; Seno M
Int J Mol Sci; 2018 Oct; 19(11):. PubMed ID: 30373174
[TBL] [Abstract][Full Text] [Related]
10. Cripto recruits Furin and PACE4 and controls Nodal trafficking during proteolytic maturation.
Blanchet MH; Le Good JA; Mesnard D; Oorschot V; Baflast S; Minchiotti G; Klumperman J; Constam DB
EMBO J; 2008 Oct; 27(19):2580-91. PubMed ID: 18772886
[TBL] [Abstract][Full Text] [Related]
11. Growth factor induction of Cripto-1 shedding by glycosylphosphatidylinositol-phospholipase D and enhancement of endothelial cell migration.
Watanabe K; Bianco C; Strizzi L; Hamada S; Mancino M; Bailly V; Mo W; Wen D; Miatkowski K; Gonzales M; Sanicola M; Seno M; Salomon DS
J Biol Chem; 2007 Oct; 282(43):31643-55. PubMed ID: 17720976
[TBL] [Abstract][Full Text] [Related]
12. Cripto localizes Nodal at the limiting membrane of early endosomes.
Blanchet MH; Le Good JA; Oorschot V; Baflast S; Minchiotti G; Klumperman J; Constam DB
Sci Signal; 2008 Nov; 1(45):ra13. PubMed ID: 19001664
[TBL] [Abstract][Full Text] [Related]
13. The threonine that carries fucose, but not fucose, is required for Cripto to facilitate Nodal signaling.
Shi S; Ge C; Luo Y; Hou X; Haltiwanger RS; Stanley P
J Biol Chem; 2007 Jul; 282(28):20133-41. PubMed ID: 17504756
[TBL] [Abstract][Full Text] [Related]
14. Conformational features and binding affinities to Cripto, ALK7 and ALK4 of Nodal synthetic fragments.
Calvanese L; Sandomenico A; Caporale A; Focà A; Focà G; D'Auria G; Falcigno L; Ruvo M
J Pept Sci; 2015 Apr; 21(4):283-93. PubMed ID: 25588905
[TBL] [Abstract][Full Text] [Related]
15. Cripto is a noncompetitive activin antagonist that forms analogous signaling complexes with activin and nodal.
Kelber JA; Shani G; Booker EC; Vale WW; Gray PC
J Biol Chem; 2008 Feb; 283(8):4490-500. PubMed ID: 18089557
[TBL] [Abstract][Full Text] [Related]
16. Enhancement of Notch receptor maturation and signaling sensitivity by Cripto-1.
Watanabe K; Nagaoka T; Lee JM; Bianco C; Gonzales M; Castro NP; Rangel MC; Sakamoto K; Sun Y; Callahan R; Salomon DS
J Cell Biol; 2009 Nov; 187(3):343-53. PubMed ID: 19948478
[TBL] [Abstract][Full Text] [Related]
17. Cripto as a target for cancer immunotherapy.
Hu XF; Xing PX
Expert Opin Ther Targets; 2005 Apr; 9(2):383-94. PubMed ID: 15934922
[TBL] [Abstract][Full Text] [Related]
18. Cripto-1: a multifunctional modulator during embryogenesis and oncogenesis.
Strizzi L; Bianco C; Normanno N; Salomon D
Oncogene; 2005 Aug; 24(37):5731-41. PubMed ID: 16123806
[TBL] [Abstract][Full Text] [Related]
19. A Nodal- and ALK4-independent signaling pathway activated by Cripto-1 through Glypican-1 and c-Src.
Bianco C; Strizzi L; Rehman A; Normanno N; Wechselberger C; Sun Y; Khan N; Hirota M; Adkins H; Williams K; Margolis RU; Sanicola M; Salomon DS
Cancer Res; 2003 Mar; 63(6):1192-7. PubMed ID: 12649175
[TBL] [Abstract][Full Text] [Related]
20. A compound-based computational approach for the accurate determination of hot spots.
Wang L; Hou Y; Quan H; Xu W; Bao Y; Li Y; Fu Y; Zou S
Protein Sci; 2013 Aug; 22(8):1060-70. PubMed ID: 23776011
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]